Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up

To improve our knowledge about head and neck paragangliomas (HN-PGL), the clinical characteristics of all the patients with HN-PGL included in the Spanish Registry were analyzed, as well as the treatment modalities and their outcomes. A total of 202 patients, 67.8% women, aged 53.1 ± 17.4, with 264...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Otolaryngology-head and neck surgery 2024-10
Hauptverfasser: Lamas, Cristina, Febrero, Beatriz, Casteràs, Anna, Romero-Lluch, Ana, Recio-Córdova, José María, Ros, Inmaculada, Iglesias, Pedro, Hanzu, Felicia A, Araujo-Castro, Marta, Guerrero-Pérez, Fernando, Ares, Jessica, Menéndez, Edelmiro, Paja, Miguel, Álvarez-Escolá, Cristina, Librizzi, Soledad, Sánchez-Sobrino, Paula, Andres-Pretel, Fernando, Calatayud, María
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Otolaryngology-head and neck surgery
container_volume
creator Lamas, Cristina
Febrero, Beatriz
Casteràs, Anna
Romero-Lluch, Ana
Recio-Córdova, José María
Ros, Inmaculada
Iglesias, Pedro
Hanzu, Felicia A
Araujo-Castro, Marta
Guerrero-Pérez, Fernando
Ares, Jessica
Menéndez, Edelmiro
Paja, Miguel
Álvarez-Escolá, Cristina
Librizzi, Soledad
Sánchez-Sobrino, Paula
Andres-Pretel, Fernando
Calatayud, María
description To improve our knowledge about head and neck paragangliomas (HN-PGL), the clinical characteristics of all the patients with HN-PGL included in the Spanish Registry were analyzed, as well as the treatment modalities and their outcomes. A total of 202 patients, 67.8% women, aged 53.1 ± 17.4, with 264 HN-PGL, from 16 Spanish hospitals, were included. Tumors were located in the carotid body in 61%, jugular bulb in 20.5%, tympanic area in 10.2%, and along the vagal nerve in 6.4%. Multiple tumors developed in 20.8% and metastatic disease in 4%. A genetic study was done in 64.4% and showed a pathogenic variant in SDHx in 50%. These patients were younger, with no sex predominance, and had more multiple and metastatic tumors. Tumors were treated by surgery in 134 patients, radiotherapy in 33, and other treatments in 20, and were observed without active treatment in 41 patients, who were older, more often asymptomatic, and had smaller tumors. Tumors treated with radiotherapy were larger and more often in locations other than the carotid body. After a median follow-up of 80 months (interquartile range: 41-136), 6.9% had died; among the survivors, 48.4% were disease-free, 42.1% stable, and 9.4% had progressed. The rate of sequelae was similar among patients submitted to surgery, radiotherapy, or observation. We could not identify any prognostic factor for progression. Most HN-PGL are localized slow-growing tumors. Long-term survival is high, even in case of metastasis. Although surgery is the most common treatment, radiotherapy and active surveillance are safe approaches.
doi_str_mv 10.1002/ohn.1012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3115969702</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3115969702</sourcerecordid><originalsourceid>FETCH-LOGICAL-c208t-615135e869fbc73f341e7c444cf62342e4c20d31ecd4367b5f37ebadb0e7e4e13</originalsourceid><addsrcrecordid>eNpFkF1LwzAYhYMobk7BXyC59CaaNGnSeDeGc8KmghteljR921XbZiYt4r-3w6-rcy4eDocHoXNGrxil0bXbtkNh0QEaM6oVkQlTh2hMmRYk1joZoZMQXimlUip1jEZccy1ZzMfIzHrvoe3wyrSmhGZfXYEXYHJs2hw_gH3DT8ab0rRlXbnGhBs8xau-7io7wODxM_gKAn6pui1eurYka_ANnru6dh9ksztFR4WpA5z95ARt5rfr2YIsH-_uZ9MlsRFNOjLcYTyGROois4oXXDBQVghhCxlxEYEYuJwzsLngUmVxwRVkJs8oKBDA-ARdfu_uvHvvIXRpUwULdW1acH1IOWOxllrR6B-13oXgoUh3vmqM_0wZTfdC00Fouhc6oBc_q33WQP4H_hrkX43FcCI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3115969702</pqid></control><display><type>article</type><title>Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up</title><source>Access via Wiley Online Library</source><creator>Lamas, Cristina ; Febrero, Beatriz ; Casteràs, Anna ; Romero-Lluch, Ana ; Recio-Córdova, José María ; Ros, Inmaculada ; Iglesias, Pedro ; Hanzu, Felicia A ; Araujo-Castro, Marta ; Guerrero-Pérez, Fernando ; Ares, Jessica ; Menéndez, Edelmiro ; Paja, Miguel ; Álvarez-Escolá, Cristina ; Librizzi, Soledad ; Sánchez-Sobrino, Paula ; Andres-Pretel, Fernando ; Calatayud, María</creator><creatorcontrib>Lamas, Cristina ; Febrero, Beatriz ; Casteràs, Anna ; Romero-Lluch, Ana ; Recio-Córdova, José María ; Ros, Inmaculada ; Iglesias, Pedro ; Hanzu, Felicia A ; Araujo-Castro, Marta ; Guerrero-Pérez, Fernando ; Ares, Jessica ; Menéndez, Edelmiro ; Paja, Miguel ; Álvarez-Escolá, Cristina ; Librizzi, Soledad ; Sánchez-Sobrino, Paula ; Andres-Pretel, Fernando ; Calatayud, María</creatorcontrib><description>To improve our knowledge about head and neck paragangliomas (HN-PGL), the clinical characteristics of all the patients with HN-PGL included in the Spanish Registry were analyzed, as well as the treatment modalities and their outcomes. A total of 202 patients, 67.8% women, aged 53.1 ± 17.4, with 264 HN-PGL, from 16 Spanish hospitals, were included. Tumors were located in the carotid body in 61%, jugular bulb in 20.5%, tympanic area in 10.2%, and along the vagal nerve in 6.4%. Multiple tumors developed in 20.8% and metastatic disease in 4%. A genetic study was done in 64.4% and showed a pathogenic variant in SDHx in 50%. These patients were younger, with no sex predominance, and had more multiple and metastatic tumors. Tumors were treated by surgery in 134 patients, radiotherapy in 33, and other treatments in 20, and were observed without active treatment in 41 patients, who were older, more often asymptomatic, and had smaller tumors. Tumors treated with radiotherapy were larger and more often in locations other than the carotid body. After a median follow-up of 80 months (interquartile range: 41-136), 6.9% had died; among the survivors, 48.4% were disease-free, 42.1% stable, and 9.4% had progressed. The rate of sequelae was similar among patients submitted to surgery, radiotherapy, or observation. We could not identify any prognostic factor for progression. Most HN-PGL are localized slow-growing tumors. Long-term survival is high, even in case of metastasis. Although surgery is the most common treatment, radiotherapy and active surveillance are safe approaches.</description><identifier>ISSN: 0194-5998</identifier><identifier>ISSN: 1097-6817</identifier><identifier>EISSN: 1097-6817</identifier><identifier>DOI: 10.1002/ohn.1012</identifier><identifier>PMID: 39396153</identifier><language>eng</language><publisher>England</publisher><ispartof>Otolaryngology-head and neck surgery, 2024-10</ispartof><rights>2024 American Academy of Otolaryngology–Head and Neck Surgery Foundation.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c208t-615135e869fbc73f341e7c444cf62342e4c20d31ecd4367b5f37ebadb0e7e4e13</cites><orcidid>0000-0003-4622-9508 ; 0000-0002-0519-0072 ; 0000-0002-9548-7821 ; 0000-0003-4719-065X ; 0000-0002-2399-4023 ; 0000-0002-1142-180X ; 0000-0001-7803-089X ; 0000-0003-0126-1985 ; 0000-0002-4890-5293 ; 0000-0002-4165-4356 ; 0000-0002-8806-2147 ; 0000-0002-0213-936X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39396153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lamas, Cristina</creatorcontrib><creatorcontrib>Febrero, Beatriz</creatorcontrib><creatorcontrib>Casteràs, Anna</creatorcontrib><creatorcontrib>Romero-Lluch, Ana</creatorcontrib><creatorcontrib>Recio-Córdova, José María</creatorcontrib><creatorcontrib>Ros, Inmaculada</creatorcontrib><creatorcontrib>Iglesias, Pedro</creatorcontrib><creatorcontrib>Hanzu, Felicia A</creatorcontrib><creatorcontrib>Araujo-Castro, Marta</creatorcontrib><creatorcontrib>Guerrero-Pérez, Fernando</creatorcontrib><creatorcontrib>Ares, Jessica</creatorcontrib><creatorcontrib>Menéndez, Edelmiro</creatorcontrib><creatorcontrib>Paja, Miguel</creatorcontrib><creatorcontrib>Álvarez-Escolá, Cristina</creatorcontrib><creatorcontrib>Librizzi, Soledad</creatorcontrib><creatorcontrib>Sánchez-Sobrino, Paula</creatorcontrib><creatorcontrib>Andres-Pretel, Fernando</creatorcontrib><creatorcontrib>Calatayud, María</creatorcontrib><title>Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up</title><title>Otolaryngology-head and neck surgery</title><addtitle>Otolaryngol Head Neck Surg</addtitle><description>To improve our knowledge about head and neck paragangliomas (HN-PGL), the clinical characteristics of all the patients with HN-PGL included in the Spanish Registry were analyzed, as well as the treatment modalities and their outcomes. A total of 202 patients, 67.8% women, aged 53.1 ± 17.4, with 264 HN-PGL, from 16 Spanish hospitals, were included. Tumors were located in the carotid body in 61%, jugular bulb in 20.5%, tympanic area in 10.2%, and along the vagal nerve in 6.4%. Multiple tumors developed in 20.8% and metastatic disease in 4%. A genetic study was done in 64.4% and showed a pathogenic variant in SDHx in 50%. These patients were younger, with no sex predominance, and had more multiple and metastatic tumors. Tumors were treated by surgery in 134 patients, radiotherapy in 33, and other treatments in 20, and were observed without active treatment in 41 patients, who were older, more often asymptomatic, and had smaller tumors. Tumors treated with radiotherapy were larger and more often in locations other than the carotid body. After a median follow-up of 80 months (interquartile range: 41-136), 6.9% had died; among the survivors, 48.4% were disease-free, 42.1% stable, and 9.4% had progressed. The rate of sequelae was similar among patients submitted to surgery, radiotherapy, or observation. We could not identify any prognostic factor for progression. Most HN-PGL are localized slow-growing tumors. Long-term survival is high, even in case of metastasis. Although surgery is the most common treatment, radiotherapy and active surveillance are safe approaches.</description><issn>0194-5998</issn><issn>1097-6817</issn><issn>1097-6817</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpFkF1LwzAYhYMobk7BXyC59CaaNGnSeDeGc8KmghteljR921XbZiYt4r-3w6-rcy4eDocHoXNGrxil0bXbtkNh0QEaM6oVkQlTh2hMmRYk1joZoZMQXimlUip1jEZccy1ZzMfIzHrvoe3wyrSmhGZfXYEXYHJs2hw_gH3DT8ab0rRlXbnGhBs8xau-7io7wODxM_gKAn6pui1eurYka_ANnru6dh9ksztFR4WpA5z95ARt5rfr2YIsH-_uZ9MlsRFNOjLcYTyGROois4oXXDBQVghhCxlxEYEYuJwzsLngUmVxwRVkJs8oKBDA-ARdfu_uvHvvIXRpUwULdW1acH1IOWOxllrR6B-13oXgoUh3vmqM_0wZTfdC00Fouhc6oBc_q33WQP4H_hrkX43FcCI</recordid><startdate>20241013</startdate><enddate>20241013</enddate><creator>Lamas, Cristina</creator><creator>Febrero, Beatriz</creator><creator>Casteràs, Anna</creator><creator>Romero-Lluch, Ana</creator><creator>Recio-Córdova, José María</creator><creator>Ros, Inmaculada</creator><creator>Iglesias, Pedro</creator><creator>Hanzu, Felicia A</creator><creator>Araujo-Castro, Marta</creator><creator>Guerrero-Pérez, Fernando</creator><creator>Ares, Jessica</creator><creator>Menéndez, Edelmiro</creator><creator>Paja, Miguel</creator><creator>Álvarez-Escolá, Cristina</creator><creator>Librizzi, Soledad</creator><creator>Sánchez-Sobrino, Paula</creator><creator>Andres-Pretel, Fernando</creator><creator>Calatayud, María</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4622-9508</orcidid><orcidid>https://orcid.org/0000-0002-0519-0072</orcidid><orcidid>https://orcid.org/0000-0002-9548-7821</orcidid><orcidid>https://orcid.org/0000-0003-4719-065X</orcidid><orcidid>https://orcid.org/0000-0002-2399-4023</orcidid><orcidid>https://orcid.org/0000-0002-1142-180X</orcidid><orcidid>https://orcid.org/0000-0001-7803-089X</orcidid><orcidid>https://orcid.org/0000-0003-0126-1985</orcidid><orcidid>https://orcid.org/0000-0002-4890-5293</orcidid><orcidid>https://orcid.org/0000-0002-4165-4356</orcidid><orcidid>https://orcid.org/0000-0002-8806-2147</orcidid><orcidid>https://orcid.org/0000-0002-0213-936X</orcidid></search><sort><creationdate>20241013</creationdate><title>Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up</title><author>Lamas, Cristina ; Febrero, Beatriz ; Casteràs, Anna ; Romero-Lluch, Ana ; Recio-Córdova, José María ; Ros, Inmaculada ; Iglesias, Pedro ; Hanzu, Felicia A ; Araujo-Castro, Marta ; Guerrero-Pérez, Fernando ; Ares, Jessica ; Menéndez, Edelmiro ; Paja, Miguel ; Álvarez-Escolá, Cristina ; Librizzi, Soledad ; Sánchez-Sobrino, Paula ; Andres-Pretel, Fernando ; Calatayud, María</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c208t-615135e869fbc73f341e7c444cf62342e4c20d31ecd4367b5f37ebadb0e7e4e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lamas, Cristina</creatorcontrib><creatorcontrib>Febrero, Beatriz</creatorcontrib><creatorcontrib>Casteràs, Anna</creatorcontrib><creatorcontrib>Romero-Lluch, Ana</creatorcontrib><creatorcontrib>Recio-Córdova, José María</creatorcontrib><creatorcontrib>Ros, Inmaculada</creatorcontrib><creatorcontrib>Iglesias, Pedro</creatorcontrib><creatorcontrib>Hanzu, Felicia A</creatorcontrib><creatorcontrib>Araujo-Castro, Marta</creatorcontrib><creatorcontrib>Guerrero-Pérez, Fernando</creatorcontrib><creatorcontrib>Ares, Jessica</creatorcontrib><creatorcontrib>Menéndez, Edelmiro</creatorcontrib><creatorcontrib>Paja, Miguel</creatorcontrib><creatorcontrib>Álvarez-Escolá, Cristina</creatorcontrib><creatorcontrib>Librizzi, Soledad</creatorcontrib><creatorcontrib>Sánchez-Sobrino, Paula</creatorcontrib><creatorcontrib>Andres-Pretel, Fernando</creatorcontrib><creatorcontrib>Calatayud, María</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Otolaryngology-head and neck surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lamas, Cristina</au><au>Febrero, Beatriz</au><au>Casteràs, Anna</au><au>Romero-Lluch, Ana</au><au>Recio-Córdova, José María</au><au>Ros, Inmaculada</au><au>Iglesias, Pedro</au><au>Hanzu, Felicia A</au><au>Araujo-Castro, Marta</au><au>Guerrero-Pérez, Fernando</au><au>Ares, Jessica</au><au>Menéndez, Edelmiro</au><au>Paja, Miguel</au><au>Álvarez-Escolá, Cristina</au><au>Librizzi, Soledad</au><au>Sánchez-Sobrino, Paula</au><au>Andres-Pretel, Fernando</au><au>Calatayud, María</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up</atitle><jtitle>Otolaryngology-head and neck surgery</jtitle><addtitle>Otolaryngol Head Neck Surg</addtitle><date>2024-10-13</date><risdate>2024</risdate><issn>0194-5998</issn><issn>1097-6817</issn><eissn>1097-6817</eissn><abstract>To improve our knowledge about head and neck paragangliomas (HN-PGL), the clinical characteristics of all the patients with HN-PGL included in the Spanish Registry were analyzed, as well as the treatment modalities and their outcomes. A total of 202 patients, 67.8% women, aged 53.1 ± 17.4, with 264 HN-PGL, from 16 Spanish hospitals, were included. Tumors were located in the carotid body in 61%, jugular bulb in 20.5%, tympanic area in 10.2%, and along the vagal nerve in 6.4%. Multiple tumors developed in 20.8% and metastatic disease in 4%. A genetic study was done in 64.4% and showed a pathogenic variant in SDHx in 50%. These patients were younger, with no sex predominance, and had more multiple and metastatic tumors. Tumors were treated by surgery in 134 patients, radiotherapy in 33, and other treatments in 20, and were observed without active treatment in 41 patients, who were older, more often asymptomatic, and had smaller tumors. Tumors treated with radiotherapy were larger and more often in locations other than the carotid body. After a median follow-up of 80 months (interquartile range: 41-136), 6.9% had died; among the survivors, 48.4% were disease-free, 42.1% stable, and 9.4% had progressed. The rate of sequelae was similar among patients submitted to surgery, radiotherapy, or observation. We could not identify any prognostic factor for progression. Most HN-PGL are localized slow-growing tumors. Long-term survival is high, even in case of metastasis. Although surgery is the most common treatment, radiotherapy and active surveillance are safe approaches.</abstract><cop>England</cop><pmid>39396153</pmid><doi>10.1002/ohn.1012</doi><orcidid>https://orcid.org/0000-0003-4622-9508</orcidid><orcidid>https://orcid.org/0000-0002-0519-0072</orcidid><orcidid>https://orcid.org/0000-0002-9548-7821</orcidid><orcidid>https://orcid.org/0000-0003-4719-065X</orcidid><orcidid>https://orcid.org/0000-0002-2399-4023</orcidid><orcidid>https://orcid.org/0000-0002-1142-180X</orcidid><orcidid>https://orcid.org/0000-0001-7803-089X</orcidid><orcidid>https://orcid.org/0000-0003-0126-1985</orcidid><orcidid>https://orcid.org/0000-0002-4890-5293</orcidid><orcidid>https://orcid.org/0000-0002-4165-4356</orcidid><orcidid>https://orcid.org/0000-0002-8806-2147</orcidid><orcidid>https://orcid.org/0000-0002-0213-936X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-5998
ispartof Otolaryngology-head and neck surgery, 2024-10
issn 0194-5998
1097-6817
1097-6817
language eng
recordid cdi_proquest_miscellaneous_3115969702
source Access via Wiley Online Library
title Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A09%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20Management%20of%20Head%20and%20Neck%20Paragangliomas:%20A%20Multicenter%20Series%20With%20Long-Term%20Follow-Up&rft.jtitle=Otolaryngology-head%20and%20neck%20surgery&rft.au=Lamas,%20Cristina&rft.date=2024-10-13&rft.issn=0194-5998&rft.eissn=1097-6817&rft_id=info:doi/10.1002/ohn.1012&rft_dat=%3Cproquest_cross%3E3115969702%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3115969702&rft_id=info:pmid/39396153&rfr_iscdi=true